Partners Group Private Equity Fund, LLC
Sponsored by Partners Group. Tender-Offer Fund structure focused on private equity.
Tender-Offer FundPrivate Equity
Refugio Research beta
Finding firmer ground in alternative investments.
Sponsored by Partners Group. Tender-Offer Fund structure focused on private equity.
Tender-Offer FundPrivate Equity
Shareholder report (Form N-CSR) · filed 2026-06-09 · period 2026-03-31
per-class statement blocks (V5 family, non-FS filer agent)
“Class A: NA $8,361,129,333 (x1), 3,987,232,302 sh, NAV $2.10 | Class I: NA $6,913,259,826 (x1), 3,112,888,648 sh, NAV $2.22 | Class M: NA $1,326,866 (x1), 597,471 sh, NAV $2.22 | Class S: NA $22,451,591 (x1), 10,698,281 sh, NAV $2.10”
Method Matched text template against the filing
Open the filing on SEC.gov · Full observation history
Shareholder report (Form N-CSR) · filed 2026-06-09 · period 2026-03-31
per-class statement blocks (V5 family, non-FS filer agent), Class I
“Class A: NA $8,361,129,333 (x1), 3,987,232,302 sh, NAV $2.10 | Class I: NA $6,913,259,826 (x1), 3,112,888,648 sh, NAV $2.22 | Class M: NA $1,326,866 (x1), 597,471 sh, NAV $2.22 | Class S: NA $22,451,591 (x1), 10,698,281 sh, NAV $2.10”
Method Matched text template against the filing
Open the filing on SEC.gov · Full observation history
Current findings ordered by severity. Each observation remains traceable to its filed source.
NAV per share fell 3.9% from $2.31 to $2.22 (2026-03-31). (Rule B11: NAV per share drop >= 2% decline month over month; Notify.)
Private-market NAVs move slowly by construction, so a 2%+ single-month markdown is a genuine valuation event, not noise.
2.31 -> 2.22 (down 3.9% vs prior period); trailing 4-period average 2.21; same period prior year 2.17; comparison interval: ~6 months (2025-09-30 -> 2026-03-31; this fund's series is observed at that frequency, so 'month over month' rules compare consecutive observations)
Source: https://www.sec.gov/Archives/edgar/data/1447247/000139834426010605/fp0098460-3_ncsr.htm | per-class statement blocks (V5 family, non-FS filer agent), Class I
NAV per share ($2.22) is -0.3% below its trailing four-observation average ($2.21) as of 2026-03-31. (Rule C23: Sustained NAV decline: NAV per share >= 2% below its trailing 4-observation average; Notify.)
Sustained NAV decline: NAV per share >= 2% below its trailing 4-observation average.
2.31 -> 2.22 (down 3.9% vs prior period); trailing 4-period average 2.21; same period prior year 2.17; breach persisted 4 consecutive periods (escalated per the two-stage ladder); comparison interval: ~6 months (2025-09-30 -> 2026-03-31; this fund's series is observed at that frequency, so 'month over month' rules compare consecutive observations)
Source: https://www.sec.gov/Archives/edgar/data/1447247/000139834426010605/fp0098460-3_ncsr.htm | per-class statement blocks (V5 family, non-FS filer agent), Class I
EQT VIII Co-Investment (D) SCSp marked down -100% (2025-12-31 $187,593,706 -> 2026-03-31 $1) with par balance unchanged (+-2%) -- a valuation mark, not a trade. Position was 1.18% of portfolio value.
Occurrence event; see the filing text for terms vs the prior arrangement.
Source: nport-diff:2026-03-31:mark:eqt viii co-investment (d) scsp
Pharmathen Topco Sarl marked down -60% (2025-09-30 $154,721,115 -> 2025-12-31 $62,518,847) with par balance unchanged (+-2%) -- a valuation mark, not a trade. Position was 0.93% of portfolio value.
Occurrence event; see the filing text for terms vs the prior arrangement.
Source: nport-diff:2025-12-31:mark:pharmathen topco sarl
NAV per share ($2.31) is 38.4% below its trailing four-observation average ($3.75) as of 2025-09-30. (Rule C23: Sustained NAV decline: NAV per share >= 2% below its trailing 4-observation average; Notify.)
Sustained NAV decline: NAV per share >= 2% below its trailing 4-observation average.
2.17 -> 2.31 (up 6.5% vs prior period); trailing 4-period average 3.75; same period prior year 2.15; breach persisted 3 consecutive periods (escalated per the two-stage ladder); comparison interval: ~6 months (2025-03-31 -> 2025-09-30; this fund's series is observed at that frequency, so 'month over month' rules compare consecutive observations)
Source: https://www.sec.gov/Archives/edgar/data/1447247/000139834425022223/fp0096342-3_ncsrs.htm | per-class statement blocks (V5 family, non-FS filer agent), Class I
NAV per share fell 74.3% from $8.36 to $2.15 (2024-09-30).
NAV per share fell 10.9% from $6.03 to $5.37 (2020-03-31).
NAV per share ($2.17) is 58.9% below its trailing four-observation average ($5.28) as of 2025-03-31.
NAV per share fell 4.0% from $8.10 to $7.78 (2022-09-30).
Net asset value, total return, capital flows, and distribution coverage across the filing record.
Filed portfolio-health facts and position changes. Missing disclosures stay visibly missing.
| Date | Position change |
|---|---|
| 2026-03-31 | EQT VIII Co-Investment (D) SCSp marked down -100% (2025-12-31 $187,593,706 -> 2026-03-31 $1) with par balance unchanged (+-2%) -- a valuation mark, not a trade. Position was 1.18% of portfolio value. |
| 2025-12-31 | Pharmathen Topco Sarl marked down -60% (2025-09-30 $154,721,115 -> 2025-12-31 $62,518,847) with par balance unchanged (+-2%) -- a valuation mark, not a trade. Position was 0.93% of portfolio value. |
| 2025-12-31 | EdgeCore Holdings, LP marked up +28% (2025-09-30 $179,338,383 -> 2025-12-31 $229,375,194) with par balance unchanged (+-2%) -- a valuation mark, not a trade. Position was 1.08% of portfolio value. |
| 2025-09-30 | KPOCH Holdings, LP marked up +32% (2025-06-30 $199,935,000 -> 2025-09-30 $263,308,875) with par balance unchanged (+-2%) -- a valuation mark, not a trade. Position was 1.21% of portfolio value. |
| 2025-06-30 | New position BLACKROCK TREASURY TRUST 062: 2.3% of portfolio value ($388,768,428) as of 2025-06-30; absent from the 2025-03-31 report. |
Stated cap: 5% of shares/quarter. The disclosed history shows no rationed period.
| Period | Requested | Filled | Cap used | Status |
|---|---|---|---|---|
| 2026-02-24 | Not disclosed | 100% | Not disclosed | filled |
| 2025-11-26 | Not disclosed | 100% | Not disclosed | filled |
| 2025-08-26 | Not disclosed | 100% | Not disclosed | filled |
| 2025-05-27 | Not disclosed | 100% | Not disclosed | filled |
| 2025-02-24 | Not disclosed | 100% | Not disclosed | filled |
| 2024-11-26 | Not disclosed | 100% | Not disclosed | filled |
| 2024-08-26 | Not disclosed | 100% | Not disclosed | filled |
| 2024-05-24 | Not disclosed | 100% | Not disclosed | filled |
| 2024-02-23 | Not disclosed | 100% | Not disclosed | filled |
| 2023-11-24 | Not disclosed | 100% | Not disclosed | filled |
| 2023-08-25 | Not disclosed | 100% | Not disclosed | filled |
| 2023-05-26 | Not disclosed | 100% | Not disclosed | filled |
| 2023-02-24 | Not disclosed | 100% | Not disclosed | filled |
| 2022-11-25 | Not disclosed | 100% | Not disclosed | filled |
| 2022-08-26 | Not disclosed | 100% | Not disclosed | filled |
| 2022-05-26 | Not disclosed | 100% | Not disclosed | filled |
| 2022-02-24 | Not disclosed | 100% | Not disclosed | filled |
| 2021-10-27 | Not disclosed | 100% | Not disclosed | filled |
| 2021-07-27 | Not disclosed | 100% | Not disclosed | filled |
| 2021-04-26 | Not disclosed | 100% | Not disclosed | filled |
| 2021-01-25 | Not disclosed | 100% | Not disclosed | filled |
| 2020-10-27 | Not disclosed | 100% | Not disclosed | filled |
| 2020-07-27 | Not disclosed | 100% | Not disclosed | filled |
| 2020-04-24 | Not disclosed | 100% | Not disclosed | filled |
| 2020-01-24 | Not disclosed | 100% | Not disclosed | filled |
| 2019-10-25 | Not disclosed | 100% | Not disclosed | filled |
| 2019-07-26 | Not disclosed | 100% | Not disclosed | filled |
| 2019-04-26 | Not disclosed | 100% | Not disclosed | filled |
| 2019-01-25 | Not disclosed | 100% | Not disclosed | filled |
| 2018-10-26 | Not disclosed | 100% | Not disclosed | filled |
| 2018-07-27 | Not disclosed | 100% | Not disclosed | filled |
| 2018-04-26 | Not disclosed | 100% | Not disclosed | filled |
| 2018-01-25 | Not disclosed | 100% | Not disclosed | filled |
| 2017-10-27 | Not disclosed | 100% | Not disclosed | filled |
| 2017-07-27 | Not disclosed | 100% | Not disclosed | filled |
| 2017-04-26 | Not disclosed | 100% | Not disclosed | filled |
| 2017-01-26 | Not disclosed | 100% | Not disclosed | filled |
| 2016-10-28 | Not disclosed | 100% | Not disclosed | filled |
| 2016-07-28 | Not disclosed | 100% | Not disclosed | filled |
| 2016-04-28 | Not disclosed | 100% | Not disclosed | filled |
| 2016-01-27 | Not disclosed | 100% | Not disclosed | filled |
| 2015-10-28 | Not disclosed | 100% | Not disclosed | filled |
| 2015-07-28 | Not disclosed | 100% | Not disclosed | filled |
| 2015-04-27 | Not disclosed | 100% | Not disclosed | filled |
| 2015-01-26 | Not disclosed | 100% | Not disclosed | filled |
| 2014-10-28 | Not disclosed | 100% | Not disclosed | filled |
| 2014-07-28 | Not disclosed | 100% | Not disclosed | filled |
| 2014-04-28 | Not disclosed | 100% | Not disclosed | filled |
| 2014-01-27 | Not disclosed | 100% | Not disclosed | filled |
| 2013-10-28 | Not disclosed | 100% | Not disclosed | filled |
| 2013-07-29 | Not disclosed | 100% | Not disclosed | filled |
| 2013-04-29 | Not disclosed | 100% | Not disclosed | filled |
| 2013-01-28 | Not disclosed | 100% | Not disclosed | filled |
| 2012-10-29 | Not disclosed | 100% | Not disclosed | filled |
| 2012-07-30 | Not disclosed | 100% | Not disclosed | filled |
| 2012-04-27 | Not disclosed | 100% | Not disclosed | filled |
| 2012-01-27 | Not disclosed | 100% | Not disclosed | filled |
| 2011-10-28 | Not disclosed | 100% | Not disclosed | filled |
| 2011-07-29 | Not disclosed | 100% | Not disclosed | filled |
| 2011-04-28 | Not disclosed | 100% | Not disclosed | filled |
| 2011-01-27 | Not disclosed | 100% | Not disclosed | filled |
Borrowings, unused capacity, and synthetic exposure are separated so unlike risks do not collapse into one ratio.
No structured financing components have been captured for this fund.
A filed share-class breakdown and terms-based role descriptions. This is not an estimate of who owns the fund.
No filed share-class terms have been captured for this fund; ownership type is therefore not inferred.
Management fee: 1.50% of nav or adjusted nav capped at 1.75pct per year. source. The Fund pays the Adviser a monthly management fee equal to 1/12th of 1.50% (1.50% on an annualized basis) of the greater of (i) the Fund's net asset value and (ii) the Fund's net asset value less cash and cash equivalents plus the total of all commitments made by the Fund that have not yet been drawn for investment. However, the Adviser has agreed that in no event will the management fee exceed 1.75% as a percentage of the Fund's net asset value.
Filed terms and recent documents remain available without crowding the primary research flow.
| Term | Description | Value | Effective |
|---|---|---|---|
| advisory_fee_schedule | The Fund pays the Adviser a monthly management fee equal to 1/12th of 1.50% (1.50% on an annualized basis) of the greater of (i) the Fund's net asset value and (ii) the Fund's net asset value less cash and cash equivalents plus the total of all commitments made by the Fund that have not yet been drawn for investment. However, the Adviser has agreed that in no event will the management fee exceed 1.75% as a percentage of the Fund's net asset value. | 1.5 pct_annual_of_nav_or_adjusted_nav_capped_at_1.75pct | Date not captured |
| leverage_ceiling | None | 300.0 pct_asset_coverage | Date not captured |
| repurchase_program_terms | Discretionary quarterly tender offer program: the Fund's Schedule TO offers have consistently stated up to 5% of net assets outstanding per quarter (most recently confirmed 2026-05-26). Partners Group Private Equity Fund, LLC | 5.0 pct_of_net_assets_per_quarter | Date not captured |
| Filed | Form | Accession |
|---|---|---|
| 2026-06-09 | N-CSR | 0001398344-26-010605 |
| 2026-06-01 | NPORT-P | 0001410368-26-056535 |
| 2026-05-18 | SC TO-I/A | 0001398344-26-009341 |
| 2026-04-28 | SC TO-I | 0001398344-26-007393 |
| 2026-03-10 | SC TO-I/A | 0001398344-26-004979 |
| 2026-03-02 | NPORT-P | 0001410368-26-021571 |
| 2026-01-27 | SC TO-I | 0001398344-26-001322 |
| 2025-12-23 | SC TO-I/A | 0001398344-25-022905 |
| 2025-12-09 | N-CSRS | 0001398344-25-022223 |
| 2025-11-28 | NPORT-P | 0001410368-25-032775 |
| 2025-10-29 | SC TO-I | 0001398344-25-019943 |
| 2025-09-16 | SC TO-I/A | 0001398344-25-018186 |
| 2025-08-29 | NPORT-P | 0001410368-25-001817 |
| 2025-07-30 | SC TO-I | 0001398344-25-014184 |
| 2025-07-29 | SC TO-I/A | 0001398344-25-014070 |